Imprint

HORN Pharmaceutical Consulting
CMC – GMP – Regulatory Affairs
Dr. Hiltrud Horn
Am Alten Schloß 1
D-76646 Bruchsal
Germany

Phone: +49 (0) 7251/305 527
Fax:     +49 (0) 7251/305 528
Mobile: +49 (0) 160/5834 213
E-mail: hiltrud.horn@horn-pharma.de

VAT identification number according to § 27a German Turnover Tax Law:
DE 225 437 871

Responsible for the content according to § 10 abbr. 3 MDStV:
Dr. Hiltrud Horn


Layout, web programming, database solutions and web hosting

ISI Software GmbH - Agentur für Neue Medien
E-Mail: mail@isi-agentur.de - Internet: www.isi-agentur.de


 

Google Analytics and Privacy Policy

This website uses Google Analytics, a web analytics service provided by Google, Inc. ("Google"). Google Analytics uses "cookies", which are text files placed on your computer, to help the website analyze how users use the site. The information generated by the cookie about your use of the website (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information for the purpose of evaluating your use of the website, compiling reports on website activity for website operators and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google's behalf. Google will not associate your IP address with any other data held by Google. You may refuse the use of cookies by selecting the appropriate settings on your browser, however please note that if you do this you may not be able to use the full functionality of this website. By using this website, you consent to the processing of data about you by Google in the manner and for the purposes set out above.

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail
EU: New Variation System in force as of Jan 1, 2010. Filing of variations will be faster, easier, and more flexible. Have you considered that your Change Control System needs to be updated accordingly?
EU: Centralised Marketing Authorisation Procedure for ATMPs needed Have you already filed your application? The time clock is ticking. Transitional periods will be over soon.

News

  • 09.01.2012
    News for the Industry
    More
  • 19.04.2010
    EU: GMP-Annex 2 revised - Details defined for biological products including ATMPs
    More
  • 11.03.2010
    EU: IMPD requirements for the Quality part of biological/biotechnology derived substances defined
    More
Get all news



Events

  • 13. - 14.03.2012
    Berlin: Change Control – New Aspects and Best Practices
    More
  • 15. - 16.03.2012
    Vienna: Handling Changes and Variations
    More
  • 22. - 23.05.2012
    Cologne: Der Regulatory Affairs Manager
    More
Get all events